Effects	effects	O	O
of	of	O	O
nonsteroidal	nonsteroidal	B_chemicals	O
anti-inflammatory	anti-inflammatory	I_chemicals	O
drugs	drugs	S_chemicals	O
on	on	O	O
hemostasis	hemostasis	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
aneurysmal	aneurysmal	O	B_disease
subarachnoid	subarachnoid	O	B_disease
hemorrhage	hemorrhage	O	S_disease
.	.	O	O

Platelet	platelet	O	O
function	function	O	O
is	is	O	O
impaired	impaired	O	O
by	by	O	O
nonsteroidal	nonsteroidal	B_chemicals	O
anti-inflammatory	anti-inflammatory	I_chemicals	O
drugs	drugs	S_chemicals	O
(	(	O	O
NSAIDs	nsaids	S_chemicals	O
)	)	O	O
with	with	O	O
prominent	prominent	O	O
anti-inflammatory	anti-inflammatory	O	O
properties	properties	O	O
.	.	O	O

Their	their	O	O
safety	safety	O	O
in	in	O	O
patients	patients	O	O
undergoing	undergoing	O	O
intracranial	intracranial	O	O
surgery	surgery	O	O
is	is	O	O
under	under	O	O
debate	debate	O	O
.	.	O	O

Patients	patients	O	O
with	with	O	O
aneurysmal	aneurysmal	O	B_disease
subarachnoid	subarachnoid	O	B_disease
hemorrhage	hemorrhage	O	S_disease
(	(	O	O
SAH	sah	O	O
)	)	O	O
were	were	O	O
randomized	randomized	O	O
to	to	O	O
receive	receive	O	O
either	either	O	O
ketoprofen	ketoprofen	S_chemicals	O
,	,	O	O
100	100	O	O
mg	mg	O	O
,	,	O	O
three	three	O	O
times	times	O	O
a	a	O	O
day	day	O	O
(	(	O	O
ketoprofen	ketoprofen	S_chemicals	O
group	group	O	O
,	,	O	O
n	n	O	O
=	=	O	O
9	9	O	O
)	)	O	O
or	or	O	O
a	a	O	O
weak	weak	O	O
NSAID	nsaid	S_chemicals	O
,	,	O	O
acetaminophen	acetaminophen	S_chemicals	O
,	,	O	O
1	1	O	O
g	g	O	O
,	,	O	O
three	three	O	O
times	times	O	O
a	a	O	O
day	day	O	O
(	(	O	O
acetaminophen	acetaminophen	S_chemicals	O
group	group	O	O
,	,	O	O
n	n	O	O
=	=	O	O
9	9	O	O
)	)	O	O
starting	starting	O	O
immediately	immediately	O	O
after	after	O	O
the	the	O	O
diagnosis	diagnosis	O	O
of	of	O	O
aneurysmal	aneurysmal	O	O
SAH	sah	O	O
.	.	O	O

Treatment	treatment	O	O
was	was	O	O
continued	continued	O	O
for	for	O	O
3	3	O	O
days	days	O	O
postoperatively	postoperatively	O	O
.	.	O	O

Test	test	O	O
blood	blood	O	O
samples	samples	O	O
were	were	O	O
taken	taken	O	O
before	before	O	O
treatment	treatment	O	O
and	and	O	O
surgery	surgery	O	O
as	as	O	O
well	well	O	O
as	as	O	O
on	on	O	O
the	the	O	O
first	first	O	O
,	,	O	O
third	third	O	O
,	,	O	O
and	and	O	O
fifth	fifth	O	O
postoperative	postoperative	O	O
mornings	mornings	O	O
.	.	O	O

Maximal	maximal	O	O
platelet	platelet	B_chemicals	O
aggregation	aggregation	I_chemicals	O
induced	induced	O	O
by	by	O	O
6	6	O	O
microM	microm	O	O
of	of	O	O
adenosine	adenosine	B_chemicals	O
diphosphate	diphosphate	S_chemicals	O
decreased	decreased	O	O
after	after	O	O
administration	administration	O	O
of	of	O	O
ketoprofen	ketoprofen	S_chemicals	O
.	.	O	O

Aggregation	aggregation	O	O
was	was	O	O
lower	lower	O	O
(	(	O	O
P	p	O	O
<	<	O	O
.05	.05	O	O
)	)	O	O
in	in	O	O
the	the	O	O
ketoprofen	ketoprofen	S_chemicals	O
group	group	O	O
than	than	O	O
in	in	O	O
the	the	O	O
acetaminophen	acetaminophen	S_chemicals	O
group	group	O	O
just	just	O	O
before	before	O	O
surgery	surgery	O	O
and	and	O	O
on	on	O	O
the	the	O	O
third	third	O	O
postoperative	postoperative	O	O
day	day	O	O
.	.	O	O

In	in	O	O
contrast	contrast	O	O
,	,	O	O
maximal	maximal	O	O
platelet	platelet	B_chemicals	O
aggregation	aggregation	I_chemicals	O
increased	increased	O	O
in	in	O	O
the	the	O	O
acetaminophen	acetaminophen	S_chemicals	O
group	group	O	O
on	on	O	O
the	the	O	O
third	third	O	O
postoperative	postoperative	O	O
day	day	O	O
as	as	O	O
compared	compared	O	O
with	with	O	O
the	the	O	O
pretreatment	pretreatment	O	O
platelet	platelet	B_chemicals	O
aggregation	aggregation	I_chemicals	O
results	results	O	O
(	(	O	O
P	p	O	O
<	<	O	O
.05	.05	O	O
)	)	O	O
.	.	O	O

One	one	O	O
patient	patient	O	O
in	in	O	O
the	the	O	O
ketoprofen	ketoprofen	S_chemicals	O
group	group	O	O
developed	developed	O	O
a	a	O	O
postoperative	postoperative	O	O
intracranial	intracranial	O	B_disease
hematoma	hematoma	O	S_disease
.	.	O	O

Coagulation	coagulation	O	O
(	(	O	O
prothrombin	prothrombin	S_chemicals	O
time	time	O	O
[	[	O	O
PT	pt	O	O
]	]	O	O
,	,	O	O
activated	activated	O	O
partial	partial	O	O
thromboplastin	thromboplastin	S_chemicals	O
time	time	O	O
[	[	O	O
APPT	appt	O	O
]	]	O	O
,	,	O	O
fibrinogen	fibrinogen	S_chemicals	O
concentration	concentration	O	O
,	,	O	O
and	and	O	O
antithrombin	antithrombin	B_chemicals	B_disease
III	iii	I_chemicals	I_disease
[	[	O	O
AT	at	O	O
III	iii	O	O
]	]	O	O
)	)	O	O
was	was	O	O
comparable	comparable	O	O
between	between	O	O
the	the	O	O
two	two	O	O
groups	groups	O	O
.	.	O	O

Ketoprofen	ketoprofen	S_chemicals	O
but	but	O	O
not	not	O	O
acetaminophen	acetaminophen	S_chemicals	O
impaired	impaired	O	O
platelet	platelet	O	O
function	function	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
SAH	sah	O	O
.	.	O	O

If	if	O	O
ketoprofen	ketoprofen	S_chemicals	O
is	is	O	O
used	used	O	O
before	before	O	O
surgery	surgery	O	O
on	on	O	O
cerebral	cerebral	O	B_disease
artery	artery	O	B_disease
aneurysms	aneurysms	O	S_disease
,	,	O	O
it	it	O	O
may	may	O	O
pose	pose	O	O
an	an	O	O
additional	additional	O	O
risk	risk	O	O
factor	factor	O	O
for	for	O	O
hemorrhage	hemorrhage	O	S_disease
.	.	O	O

